Literature DB >> 15130941

Regulation of monocyte migration by amphoterin (HMGB1).

Ari Rouhiainen1, Juha Kuja-Panula, Erika Wilkman, Jukka Pakkanen, Jan Stenfors, Raimo K Tuominen, Mauri Lepäntalo, Olli Carpén, Jaakko Parkkinen, Heikki Rauvala.   

Abstract

Amphoterin (HMGB1) is a 30-kD heparin-binding protein involved in process extension and migration of cells by a mechanism involving the receptor for advanced glycation end products (RAGE). High levels of amphoterin are released to serum during septic shock. We have studied the expression of amphoterin in monocytes and the role of amphoterin and RAGE in monocyte transendothelial migration. Un-activated monocytes in suspension did not reveal amphoterin on their surface, but adherent monocytes exported amphoterin to the cell surface. Immunohistochemical staining of arterial thrombi in vivo revealed amphoterin in mononuclear cells and in surrounding extracellular matrix. Amphoterin was secreted from phorbol ester and interferon-gamma (IFN-gamma)-activated macrophages, and the secretion was inhibited by blocking the adenosine 5'-triphosphate (ATP)-binding cassette transporter-1, a member of the multidrug resistance protein family. Amphoterin was specifically adhesive for monocytes in peripheral blood leukocyte adhesion assay. Adhesion caused an extensive spreading of cells, which was inhibited by the dominant-negative RAGE receptor (soluble ectodomain of RAGE), and adhesion up-regulated chromogranin expression in monocytes, also suggesting a RAGE-dependent interaction. Monocyte transendothelial migration was efficiently inhibited by anti-amphoterin and anti-RAGE antibodies and by the soluble RAGE. We suggest that amphoterin is an autocrine/paracrine regulator of monocyte invasion through the endothelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130941     DOI: 10.1182/blood-2003-10-3536

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  87 in total

Review 1.  High-mobility group box 1 protein and its role in severe acute pancreatitis.

Authors:  Xiao Shen; Wei-Qin Li
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways.

Authors:  Wenchang Huang; Yiyun Liu; Lei Li; Ruyuan Zhang; Wei Liu; Jun Wu; Enqiang Mao; Yaoqing Tang
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages.

Authors:  Yan Chen; Guangping Li; Yanxia Liu; Victoria P Werth; Kevin Jon Williams; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2016-03-09       Impact factor: 6.384

4.  S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway.

Authors:  Leying Zhang; Wei Liu; Darya Alizadeh; Dongchang Zhao; Omar Farrukh; Jeffrey Lin; Sam A Badie; Behnam Badie
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

5.  Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of Toll-like receptor-4 and increased cell-matrix adhesiveness.

Authors:  Shipan Dai; Chhinder Sodhi; Selma Cetin; Ward Richardson; Maria Branca; Matthew D Neal; Thomas Prindle; Congrong Ma; Richard A Shapiro; Bin Li; James H-C Wang; David J Hackam
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

6.  Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.

Authors:  Konstantin Stark; Vanessa Philippi; Sven Stockhausen; Johanna Busse; Antonella Antonelli; Meike Miller; Irene Schubert; Parandis Hoseinpour; Sue Chandraratne; Marie-Luise von Brühl; Florian Gaertner; Michael Lorenz; Alessandra Agresti; Raffaele Coletti; Daniel J Antoine; Ralf Heermann; Kirsten Jung; Sven Reese; Iina Laitinen; Markus Schwaiger; Axel Walch; Markus Sperandio; Peter P Nawroth; Christoph Reinhardt; Sven Jäckel; Marco E Bianchi; Steffen Massberg
Journal:  Blood       Date:  2016-08-29       Impact factor: 22.113

Review 7.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

8.  S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.

Authors:  Huaqing Wang; Leying Zhang; Ian Y Zhang; Xuebo Chen; Anna Da Fonseca; Shihua Wu; Hui Ren; Sam Badie; Sam Sadeghi; Mao Ouyang; Charles D Warden; Behnam Badie
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

9.  Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.

Authors:  A Uzawa; M Mori; J Taniguchi; S Masuda; M Muto; S Kuwabara
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

10.  Linking innate and adaptive immunity: human Vgamma9Vdelta2 T cells enhance CD40 expression and HMGB-1 secretion.

Authors:  Shirin Kalyan; Anthony W Chow
Journal:  Mediators Inflamm       Date:  2009-10-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.